Patients at highest risk of becoming seriously ill from COVID-19 are eligible for antiviral treatments on the NHS. From the 1st July 2023, patients will have to pay the NHS prescription charge if prescribed oral antivirals.

Eligible patients include some patients with cancer, blood conditions, kidney disease (CKD), liver disease and autoimmune conditions, among others.

GP reception staff must arrange an appointment with the clinical team if a patient calls and says they are eligible for these treatments.

Cohort eligibility expanded in May 2023, with additional conditions added including: any mature T-Cell malignancy, respiratory conditions and new neurological disorders which have recently been added to the IAG report.

Letters will be sent to patients within eligible treatment cohorts from NHSE from the 5th of June. Letters are advising patients who think they may be eligible for treatment to contact their GP or NHS111